Malaria Vaccine Delivery Platforms

This project is looking at the development of a blood stage vaccine against the Plasmodium falciparum species of malaria.

Two leading candidate antigens are currently being assessed including MSP2 and EBA175.

These projects are assessing the use of different vaccine adjuvants to determine which induce optimum functional responses and to ascertain the influence of adjuvants in biasing epitope specific responses and IgG subclass responses.

Health Issue

Contact Details

For any general enquiries relating to this project, please contact:

Associate Professor Jack Richards

Group Head, NHMRC Postdoctoral Fellow, Infectious Diseases Physician